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ABSTRACT 
 
Radical orchifunicolectomy has traditionally been the 
main clinical treatment for small testicular masses (STMs); 
however STMs represent a constantly increasing and often 
incidental finding. Since many of them result benign, a more 
conservative testis-sparing surgery was proposed, but it 
requires a preliminary differentiation between benign and 
malignant masses: this however remains challenging. 
Although common understanding in radiology and oncology 
is that perfusion patterns might provide a useful information 
about the type of masses, no guidelines or consensus is 
available for the differentiation of STMs. 
We propose to build a dictionary of relevant perfusion 
patterns, extracted using non-negative matrix factorization on 
pixel-wise time-intensity curves from contrast-enhanced 
ultrasound data.  
When data from a lesion are reconstructed using this 
dictionary, a vector containing the frequency of utilization of 
each pattern can be used as a tissue signature.  
Using this signature, a support vector machine classifier has 
been trained, and the cross validated accuracy reached 100% 
in our pilot cohort.    
 
Index Terms— CEUS, ultrasound non-negative matrix 
factorization, dictionary learning, SVM, cancer 
 
 
1. INTRODUCTION 
 
Testicular tumours has been increasing for many decades. 
Despite its relatively low incidence, they contribute to 
approximately 1% of all malignancies in males, they appear 
at a young age adversely affecting the quality of life of 
patients. The majority of testicular tumours arise from 
spermatogenic cells (germ cells) and are almost uniformly 
malignant. Non-germ cell tumours represent the remainder of 
primary and secondary testicular tumours, and they consist of 
sex cord stromal tumours (Leydig or Sertoli cell tumours), 
lymphoma and metastasis [1]; in particular Leydig cell 
tumours (LCT) are benign and are elective for testis-sparing 
surgery.   
  
 
Figure 1 Effects of tissue heterogeneity. The perfusion parameters 
extracted from the average TIC (black line, right panels) of a region 
of interest (red outline, left panel), can be markedly different from 
those estimated on TICs extracted from sub-regions (green and blue 
lines). 
Ultrasound is the first-line imaging technique for many 
testicular diseases, being a sensitive and accurate technique 
for the detection of testicular abnormalities. Additionally, 
ultrasound is the one scrotal imaging technique that a patient 
will undergo prior to surgery. However, even if B-mode 
ultrasound proves extremely sensitive for the detection of 
testicular masses, it does not provide the possibilities of 
differentiating the tumours type, i.e. histological diagnosis, 
which could potentially result in a conservative surgical 
approach [2]. Currently, there are no ultrasound criteria that 
allow definitive differentiation of benign from malignant 
testicular lesions [1], so that the diagnosis can only be carried 
out with an histological examination.  Unfortunately, at 
variance with many cancers, where a biopsy can be obtained, 
the only way to examine a testicular lump is by removing the 
affected testicle completely [3].  
One of the most important parameters for assessing the tumor 
status of a particular tissue is the degree of vascularization, 
since it reflects the metabolic requirements of the surrounding 
tissue, characterizes tissue pathology, and impacts the 
effectiveness of the therapy [4]. The macroscopic 
characteristics of tumor microvasculature are very different 
from those of a normal one [5], that is reflected in an altered 
and heterogeneous blood flow. [6]. 
Contrast-enhanced ultrasound (CEUS) has become an 
important part of clinical radiography to observe blood 
perfusion in organs and measure blood flow rate. It is 
obtained by imaging an ultrasound contrast agent composed 
by microbubbles whose size constrain them to remain 
confined purely intravascular. Traditionally,  a set of 
parameters are extracted from the CEUS data to quantify the 
perfusion patterns [7] [8] [9], and they have been proposed as 
biomarkers of therapeutic response in human cancers [10] 
[11]. However, even if has been reported that the use of 
CEUS improves the characterization of testicular lesions, 
through the qualitative evaluation of vascular flow [12], the 
use of CEUS-derived parameters showed limited success in 
differentiating testicular masses [13]. 
At variance with other data-driven approaches where 
overcomplete dictionaries of patterns are learnt [14], we 
propose to build a dictionary using a limited set of patterns 
estimated by means of Non-negative Matrix Factorization 
(NMF). The identification of the patterns in the dictionary in 
unknown lesions provide a tissue signature that may be used 
to assess its malignancy.  
2. MATERIALS 
 
A retrospective analysis of testicular CEUS data from 20 
histologically proven testicular lesions (10 seminoma and 10 
LCT; size mean: 11.4 mm, range: 3 mm - 28.6 mm) were 
performed. Ethics approval for reporting was granted from 
each patient to report this retrospective analysis. 
Ultrasound examinations were performed with Acuson 
Sequoia™ or a S2000™ system (Siemens Medical Solutions, 
Mountain View, CA): CEUS data were acquired using 
harmonic imaging with a low–mechanical index technique 
(Cadence contrast pulse sequencing (CPS™); Siemens 
Medical Solutions, Mountain View, CA)) with mechanical 
index set at or below 0.10 dB/cm/MHz, after the 
administration of a bolus of 4.8 mL of SonoVue™ (Bracco 
SpA, Milan, Italy), a sulfur hexafluoride microbubble 
contrast agent is injected, followed by 10 mL of normal saline 
via an antecubital vein cannula. An imaging plane is fixed 
and investigated. Continuous observation was usually 
performed from the time of arrival and the lesion of the 
microbubbles for at least 90 seconds in most cases (some 
cases may have reduced periods of observation), using split-
screen mode so that matched CEUS and B-mode frames are 
available at any time point. 
Figure 2 Supervised training phase. From each patient, pixel-wise perfusion curves are extracted and decomposed with NMF into a fixed 
number of components. All components from all patients create a dictionary that is used to sparsely reconstruct the pixel-wise perfusion 
curves, obtaining the perfusion signature for each patient. This is used as feature input to train a SVM classifier. 
3. METHODS 
 
3.1 Preprocessing 
Ultrasound data for each patient underwent the same 
preprocessing steps, separately.  
First, in order to correct for rigid translation of the field of 
view, a frame by frame registration is applied to the 
ultrasound data: a user-defined B-mode frame is used as 
reference, and all other frames are registered to the reference  
using phase correlation method [15]; the estimated 
transformation is then applied to all corresponding CEUS 
frames.  
Then, an expert radiologist outlined the region of interest, and  
all time-intensity curves (TIC) from the pixels within the 
outlined region are extracted. 
In order to account for non-zero baseline signal, this is 
estimated as the average intensity in the frames before the 
time of arrival of the contrast and subtracted from the original 
data [8]. By this means, all pixel-wise TICs start from zero 
intensity.  
Finally, TICs are regularized using a cubic smoothing spline 
and aligned by shifting in time the curves so to have the same 
time to peak, set equal to an arbitrary reference value for all 
patients. 
  
3.2 Perfusion curve decomposition 
Many real-world data are non-negative and the corresponding 
hidden components express physical or physiological 
meanings only when the non-negative condition are imposed 
[16]. In particular this is especially true when dealing with 
signals that represent the appearance of a contrast agent 
within a region. This will also impose than when imaging a 
discrete region (pixel or voxel), the observed intensity can be 
only a positive summation of the underlying contribution, 
coming from possibly heterogenous tissues (partial volume 
effect).  The decomposition of the observed signals into 
components that are at the same time positive and additive is 
not ensured by commonly used methods as Singular Value 
Decomposition, Principal Component Analysis, or 
Independent Component Analysis. At variance with the 
aforementioned methods, Nonnegative Matrix Factorization 
(NMF) imposes the non-negativity constraint on the 
factorizing matrices so that NMF allows only additive but not 
subtractive combinations during the factorization and the 
estimated components are forced to take only positive values. 
This result in parts-based representation of the data, which 
can discover hidden components that have specific structures 
and physical or physiological meanings. 
If all TICs extracted from a region of the CEUS data of the 
𝑝𝑡ℎ patient are stacked into a matrix 𝑌𝑝 ∈ ℳ
𝑁×𝑇, where 𝑁 is 
the number of pixels and 𝑇 is the number of time samples, 
NMF tries to find a matrix 𝑋𝑝 ∈ ℳ
𝐶×𝑇   of 𝐶 non-negative 
components of 𝑇 time samples, that can be added using non-
negative weights 𝑊𝑝 ∈ ℳ
𝑁×𝐶 to provide an approximation 
of the original data 𝑌𝑝: 
argmin
𝑋𝑝≥0,𝑊𝑝≥0
‖𝑌𝑝 − 𝑊𝑝𝑋𝑝‖2
2
 
 
The number of components is fixed and represent a parameter 
of the method, so that for each patient 𝐶 components are 
extracted. 
 
3.3 Tissue perfusion signature 
After all 𝐶 components from all 𝑃 patients in the dataset are 
extracted, they are used as words of a dictionary 𝒟, that is 
thus composed of 𝐶 ∙ 𝑃  perfusion components. 
Figure 3 Test phase. The perfusion curves extracted from the CEUS data of a suspect mass with unknown diagnosis are 
reconstructed using the learnt dictionary, and the resulting signature is fed to the SVM to classify the tissue as benign (LCT) 
or malignant (seminoma). 
When the data from a patient 𝑝 are available, all 𝑁𝑝 perfusion 
curves are stacked in the data matrix 𝑌𝑝, and can then be 
approximated as a non-negative and sparse linear 
combination of the patterns in the dictionary 𝒟. This is 
achieved by solving the non-negative LASSO optimization: 
 
argmin
𝐴∈ℝ𝑁𝑝×𝐶∙𝑃
‖𝑌𝑝 − 𝐴𝒟‖2
2
𝑠. 𝑡. {
‖𝐴𝑖,−‖1 ≤ 𝜇
𝐴𝑖,− ≥ 0
   ∀𝑖 = 1, … , 𝑁 
 
where 𝐴𝑖,− is the 𝑖
𝑡ℎ rows of the coefficient matrix 𝐴 ∈
ℝ𝑁𝑝×𝐶∙𝑃. A tissue perfusion signature 𝒮𝑝 ∈ ℝ
𝐶∙𝑃can be 
obtained using the frequency with which each pattern in 𝒟 is 
used to reconstruct an element in  𝑌𝑝. Each 𝑗
𝑡ℎ  element in the 
signature, with  𝑗 = 1, … , 𝐶𝑃 can be obtained as: 
   
𝒮𝑝(𝑗) = ‖𝐴−,𝑗‖0 /𝑁𝑝 
 
being 𝐴−,𝑗 the 𝑗
𝑡ℎ column of 𝐴.  
 
3.4 Classification 
A SVM with a linear kernel has been trained (see Fig. 2 for 
the entire training pipeline) using the tissue signature 𝒮𝑝 from 
each patient as feature vector, and the corresponding binary 
diagnosis (malignant seminoma or benign LCT) as target 
class. When a new patient with a lesion of unknown diagnosis 
is evaluated, the classification pipeline is exemplified in 
Fig.3, where the dictionary   𝒟 and the SVM classifier is 
available from the previous training phase.  
 
4. RESULTS 
 
The whole procedure (NMF decomposition, dictionary 
building, SVM training) underwent 10-fold cross validation. 
It is worth noting that to ensure a balanced training set, we 
split the data making sure that in each fold a seminoma and 
an LCT patient were present.   
The number of components has been heuristically fixed to 
𝐶=2 to keep the dictionary size limited and to avoid the 
decomposition in un-physiological curves, the sparsity 
parameter in the LASSO optimization has been set to 𝜇 =
0.01 and the penalty parameter C in the SVM is set to 3. 
The resulting test accuracy is 100%. 
 
5. CONCLUSIONS 
 
We propose a data-driven pipeline that extract relevant 
perfusion patterns from the pixel-wise time-intensity curves 
from contrast-enhanced ultrasound data of lesions with 
known histology. The presence of this patterns in data from 
unknown lesions provide a tissue signature that might be used 
to classify the lesion as benign (LCT) or malignant 
(seminoma). Despite the perfect classification obtained, it is 
worth noting the limited number of patient in the cohort, so 
that the results, although promising, should be validated on 
larger dataset. 
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